Aquí tienes una versión más corta para X:

Solo el 5% de 7.000 enfermedades raras tiene tratamiento.
300M+ personas siguen esperando.

Las terapias de ARN están cambiando eso 🧬
El cambio ya empezó 🚀

#RareDiseases #RNATherapy #Biotech

A new RNA therapy could help the heart repair itself after a heart attack – BioNews Central Researchers describe an RNA therapy designed to enhance the heart’s natural ability to protect and repair itself after injury. ...

Researchers describe an #RNATherapy designed to enhance the #heart’s natural ability to protect and repair itself after injury. 
#HeartDisease #HeartAttack #HeartRepair #CardiacRegeneration

🔊 #D2RProjectSpotlight: D2R - Health Data Science (D2R-HeDS) platform 💡 Scientific Director: Guillaume Bourque (@McGillu) 🔗 Learn more: buff.ly/qDphDDy
#RNA #RNATherapy #RNAResearch

Live webinar: How to Build a Measurable Evidence Engine for Cell, Gene and RNA Therapies. Thursday, March 12 at 8am PDT/11am EDT/3pm GMT/4pm CET. Speaker: Todd Oakland, SVP & GM of Biopharma at DNAnexus, Bruce Church, Ph.D., EVP, Research & Early Development, Aitia Bio.

Move beyond disconnected workflows and turn your datasets into an engine that supports clinical decision-making at scale. xtalks.com/webinars/how...

#Pharma #Multiomics #DrugDevelopment #AI #GeneTherapy #CellTherapy #RNATherapy

New RNA Molecule Shows Promise for HR+ Breast Cancer Treatment | Medical Xpress posted on the topic | LinkedIn A newly identified long noncoding RNA molecule shows promise as a targeted therapy for hormone receptor-positive (HR+) breast cancer, the most common form of the disease. This RNA-based approach demon...

Scientists have identified RNA molecule that selectively destroys hormone receptor-positive breast cancer cells and activates the immune system against them. Could be a game-changer for the most common form of breast cancer. #BreastCancer #RNAtherapy #TCSC
👉 www.linkedin.com/posts/medica...

🧬#Sefaxersen targets complement #FactorB mRNA, reducing FactorB and blocking the alternative pathway. Now in Phase3 IMAGINATION, this #RNAtherapy offers high specificity, long-acting effects, and potential disease-modifying benefits for kidney disease.
#Kidney #PrecisionMedicine

Scientists Create First-Ever Drug to Destroy Cancer’s “Immortality” RNA A research team has unveiled a small molecule that hunts down a cancer-enabling RNA and quietly erases it. Researchers have designed a groundbreaking drug molecule capable of precisely eliminating TER...

Scientists Create First-Ever Drug to Destroy Cancer’s “Immortality” RNA!
Researchers have developed a small molecule that targets and destroys TERRA RNA; helping halt tumour growth.
#CancerResearch #Oncology #MedicalBreakthrough #RNAtherapy #TCSC #Tumour

scitechdaily.com/scientists-c...

🧬 Professor Carl Ernst and his team are leading a groundbreaking RNA therapy project aimed at treating Schinzel-Giedion Syndrome supported by D2R’s Translational Impact Research program.

🔗 Learn more: buff.ly/0X51szG

#RareDisease #RNAtherapy
@mcgillscience.bsky.social
@theneuro.bsky.social

ten23 health and Neumirna partner to advance RNA therapy for epilepsy The collaboration seeks to advance NMT.001, an RNA-based therapy targeting microRNAs involved in drug-resistant epilepsy.

ten23 health and Neumirna Therapeutics have joined forces to advance NMT.001, an RNA-based therapy aimed at treating drug-resistant epilepsy.

#News #RNAtherapy #EpilepsyResearch #BiotechInnovation #ten23health #NeumirnaTherapeutics #Neurology #OligonucleotideTherapy #LifeSciences

ten23 health and Neumirna partner to advance RNA therapy for epilepsy The collaboration seeks to advance NMT.001, an RNA-based therapy targeting microRNAs involved in drug-resistant epilepsy.

ten23 health and Neumirna Therapeutics have joined forces to advance NMT.001, an RNA-based therapy aimed at treating drug-resistant epilepsy.

#News #RNAtherapy #EpilepsyResearch #BiotechInnovation #ten23health #NeumirnaTherapeutics #Neurology #OligonucleotideTherapy #LifeSciences

RNA-Based Therapeutics Market Size, Growth Statistics 2035 RNA-Based Therapeutics Market projected to grow at 10.32 % CAGR, reaching USD 25.01 Billion by 2035, driving growth global trends, competitive industry analysis and outlook 2025-2035.

The RNA Therapeutics Market drives innovation in gene and vaccine therapies. 🧬💉 www.marketresearchfuture.com/reports/rna-... #RNAtherapy #Biotech #PharmaInnovation

A new strategy for the extrahepatic delivery of lipid-based nanomedicines: a protein corona-mediated selective targeting system based on an ionizable cationic lipid library Applying lipid nanoparticle (LNP) technology to ribonucleic acid (RNA) nanomedicines was integral to the success of mRNA vaccines against COVID-19. To expand the power of LNP technology, extrahepatic…

🧬✨Protein corona unlocks targeted RNA delivery beyond the liver. Discover the future of LNPs with this review article by H. Harashima and co-workers from Hokkaido University.

buff.ly/buQbsMC

#Nanomedicine #RNAtherapy #DrugDelivery

#ICYMI, CPI — part of @hvmcatapult.bsky.social — announced last week that it is to host the £30 million UK RNA Biofoundry to help fast-track next-gen RNA therapies 🧬

🔗 https://loom.ly/Jt-T0OQ

#CatapultNetwork #RNAtherapy

🧬 This Taiwanese biotech startup is taking on one of medicine’s toughest challenges: fibrosis with a groundbreaking nucleic acid therapy.

Read: 👉 www.sparknify.com/post/this-ta...

#Biotech #Fibrosis #IPF #RNAtherapy #TaiwanStartups #Healthtech #Sparknify

See you next week campers! 🏕️

Choose your own adventure! Build the perfect #plasmid, interpret #nanopore results, create your own #RNAtherapy, master #mulitomics, and plan your first #proteomics experiment! DIY workshops, grants, games, and campfire stories.

Learn more: hubs.ly/Q03qwwYs0

7/7
RNatives is redefining what's possible in gene therapy.
By harnessing the power of RNA, they're turning the body's own mechanisms into medicine.

👉 Ready to see where this innovation leads?
#RNAtherapy #GeneRegulation #BiotechInnovation

🔊#D2RProjectSpotlight: RNA therapy for Schinzel-Giedion Syndrome (SGS)

🧬Led by Carl Ernst at @mcgill.ca, this project aims to develop RNA therapy for SGS, a rare genetic disease affecting the brain & lungs

🔗Learn more: buff.ly/b4ugUp8
#RareDisease #RNATherapy
@mcgill-research.bsky.social

One Injection Every Six Months Could Revolutionize Hypertension Care A new RNA-based injection, given twice a year, has been shown to lower blood pressure more effectively than standard drugs—offering new hope for millions.

What if controlling high blood pressure could be as simple as two injections a year? New research points to a game-changing future. #Hypertension #RNAtherapy #HeartHealth

www.preprints.org/manuscript/2... Excited to share our latest preprint:
🧬 “Brogidirsen and Exon 44 Skipping for DMD: Advances and Challenges in RNA-Based Therapy”
📄 www.preprints.org/manuscript/2...
Proud of Annie Tang’s excellent work leading this review. #DMD #RNAtherapy #exonskipping #ASO

Thank you for joining us at #PEGS2025! Catch us again at GENEWIZ Summer Camp June 9-13! 🏕️

Learn to build the perfect #plasmid, interpret #nanopore results, create an #RNATherapy, master #mulitomics, and plan your first #proteomics experiment!

Join us at the campfire: web.genewiz.com/summer-camp

Pharmacokinetics and Safety Profile of SNS812, a First in Human Fully Modified siRNA Targeting Wide‐Spectrum SARS‐CoV‐2, in Healthy Subjects Severe acute respiratory syndrome caused by the coronavirus (SARS-CoV-2) in the COVID-19 pandemic has highlighted the need for effective treatments, as rapid viral mutations complicate therapeutic de....

🚨New data on inhaled siRNA therapies for respiratory viruses!
ascpt.onlinelibrary.wiley.com/doi/10.1111/...
#COVID19 #SARSCoV2 #Antivirals #ClinicalTrials #RNAtherapy #Phase1Trial

CRISPR–Cas13: Pioneering RNA Editing for Nucleic Acid Therapeutics | BioDesign Research The CRISPR–Cas13 system has emerged as a revolutionary tool for RNA editing, offering new opportunities for the development of nucleic acid therapeutics. Unlike DNA-targeting CRISPR–Cas9, Cas13 target...

CRISPR-Cas13 revolutionizes RNA editing, addressing therapy challenges #RNATherapy
Details: spj.science.org/doi/10.34133/bdr.0041

CRISPR–Cas13: RNA editing tool, challenges & transformative potential #RNATherapy
Details: spj.science.org/doi/10.34133/bdr.0041

🧬 RNA-based therapies are changing oncology.

circPSAP is showing promise as a marker for survival and drug resistance in multiple myeloma. Could targeting it lead to more effective treatments?

🔗 youtube.com/shorts/J0nvr...

#CancerResearch #RNAtherapy #Oncology